Latest News about TAK
Recent news which mentions TAK
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Today 8:15 EST
From Benzinga
Takeda Seeks Approval For Moderna's COVID-19 Shot In Japan
Today 5:46 EST
From Benzinga
Why Ovid, KemPharm, Sorrento, Aquestive Are Rallying
March 03, 2021
From Benzinga
Ovid Shares Rally On Soticlestat Development Pact With Takeda In Rare Epilepsy Syndromes
March 03, 2021
From Benzinga
The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study
March 03, 2021
From Benzinga
From Benzinga
Takeda Divests Four Diabetes Products In Japan To Teijin Pharma
February 26, 2021
From Benzinga
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
February 24, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: European Regulatory Nod For Xeris, Amicus Falls On Data, 4 IPOs, FDA Decision For Mallinckrodt's StrataGraft Delayed
February 12, 2021
From Benzinga
Takeda's Maribavir Hits Primary Endpoint Goal In Late-Stage Study In Transplant Recipients
February 12, 2021
From Benzinga
Can KalVista Pharmaceuticals Stock Fly Higher?
February 10, 2021
From Motley Fool
From Benzinga
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
February 06, 2021
From Benzinga
Why Moderna Is Shooting Higher Today
January 21, 2021
From Motley Fool
A Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth Through 2021
January 06, 2021
From Benzinga
From Benzinga
2 Ultra-High-Growth Healthcare Stocks That Are Just Getting Started
December 23, 2020
From Motley Fool
Why Nano-Cap Xenetic Biosciences Is Skyrocketing
December 09, 2020
From Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
From Benzinga
The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs
December 04, 2020
From Benzinga
How Much Can Companies Make From Coronavirus Vaccines?
December 02, 2020
From Motley Fool
The Week Ahead In Biotech: Hematology Conference Gets Underway, Vanda And BioCryst Await FDA Decisions
November 29, 2020
From Benzinga
3 Best Biotech Stocks to Buy in November
November 18, 2020
From Motley Fool
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
From Benzinga
Moderna Q3 Revenues Beat Estimates, Inks Coronavirus Vaccine Supply Deal With Japan
October 29, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
October 29, 2020
From Benzinga
Earnings Scheduled For October 29, 2020
October 29, 2020
From Benzinga
The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings
October 27, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.